S&P 500   3,970.16 (+0.92%)
DOW   33,880.83 (+0.84%)
QQQ   283.80 (+1.17%)
AAPL   142.96 (+1.43%)
MSFT   246.19 (+0.74%)
META   114.94 (+0.89%)
GOOGL   93.87 (-1.13%)
AMZN   90.53 (+2.34%)
TSLA   174.07 (+0.02%)
NVDA   168.10 (+4.28%)
NIO   13.32 (+5.88%)
BABA   92.81 (+5.07%)
AMD   70.73 (+0.84%)
T   19.27 (-0.16%)
MU   55.42 (+2.97%)
CGC   3.20 (-1.23%)
F   13.19 (+0.69%)
GE   84.44 (-0.66%)
DIS   92.72 (+0.62%)
AMC   6.33 (+4.63%)
PYPL   75.25 (+1.12%)
PFE   50.70 (+0.92%)
NFLX   310.16 (+0.56%)
S&P 500   3,970.16 (+0.92%)
DOW   33,880.83 (+0.84%)
QQQ   283.80 (+1.17%)
AAPL   142.96 (+1.43%)
MSFT   246.19 (+0.74%)
META   114.94 (+0.89%)
GOOGL   93.87 (-1.13%)
AMZN   90.53 (+2.34%)
TSLA   174.07 (+0.02%)
NVDA   168.10 (+4.28%)
NIO   13.32 (+5.88%)
BABA   92.81 (+5.07%)
AMD   70.73 (+0.84%)
T   19.27 (-0.16%)
MU   55.42 (+2.97%)
CGC   3.20 (-1.23%)
F   13.19 (+0.69%)
GE   84.44 (-0.66%)
DIS   92.72 (+0.62%)
AMC   6.33 (+4.63%)
PYPL   75.25 (+1.12%)
PFE   50.70 (+0.92%)
NFLX   310.16 (+0.56%)
S&P 500   3,970.16 (+0.92%)
DOW   33,880.83 (+0.84%)
QQQ   283.80 (+1.17%)
AAPL   142.96 (+1.43%)
MSFT   246.19 (+0.74%)
META   114.94 (+0.89%)
GOOGL   93.87 (-1.13%)
AMZN   90.53 (+2.34%)
TSLA   174.07 (+0.02%)
NVDA   168.10 (+4.28%)
NIO   13.32 (+5.88%)
BABA   92.81 (+5.07%)
AMD   70.73 (+0.84%)
T   19.27 (-0.16%)
MU   55.42 (+2.97%)
CGC   3.20 (-1.23%)
F   13.19 (+0.69%)
GE   84.44 (-0.66%)
DIS   92.72 (+0.62%)
AMC   6.33 (+4.63%)
PYPL   75.25 (+1.12%)
PFE   50.70 (+0.92%)
NFLX   310.16 (+0.56%)
S&P 500   3,970.16 (+0.92%)
DOW   33,880.83 (+0.84%)
QQQ   283.80 (+1.17%)
AAPL   142.96 (+1.43%)
MSFT   246.19 (+0.74%)
META   114.94 (+0.89%)
GOOGL   93.87 (-1.13%)
AMZN   90.53 (+2.34%)
TSLA   174.07 (+0.02%)
NVDA   168.10 (+4.28%)
NIO   13.32 (+5.88%)
BABA   92.81 (+5.07%)
AMD   70.73 (+0.84%)
T   19.27 (-0.16%)
MU   55.42 (+2.97%)
CGC   3.20 (-1.23%)
F   13.19 (+0.69%)
GE   84.44 (-0.66%)
DIS   92.72 (+0.62%)
AMC   6.33 (+4.63%)
PYPL   75.25 (+1.12%)
PFE   50.70 (+0.92%)
NFLX   310.16 (+0.56%)
NASDAQ:TVTX

Travere Therapeutics - TVTX SEC Filings & 10K Form

$20.20
-0.01 (-0.05%)
(As of 12/8/2022 10:49 AM ET)
Add
Compare
Today's Range
$20.03
$20.42
50-Day Range
$18.99
$26.14
52-Week Range
$18.70
$31.65
Volume
3,846 shs
Average Volume
700,854 shs
Market Capitalization
$1.30 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.25

Recent Travere Therapeutics SEC Filings

DateFilerForm TypeView
10/28/2022
3:30 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G
10/27/2022
4:01 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/27/2022
3:17 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2022
4:05 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2022
7:10 PM
Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2022
3:05 PM
Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2022
5:20 PM
Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2022
5:19 PM
Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/22/2022
3:43 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2022
3:06 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/17/2022
4:20 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K/A
08/04/2022
4:08 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2022
6:06 AM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2022
3:55 PM
Deep Track Capital, LP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G
05/12/2022
7:49 PM
ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2022
7:47 PM
REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2022
7:45 PM
Clague Laura (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2022
7:44 PM
Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2022
7:42 PM
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Williams Brinkley Ruth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2022
7:40 PM
Squarer Ron (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2022
4:26 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2022
3:41 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2021
8:17 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2021
5:16 PM
Brinkley Ruth Williams (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2021
5:14 PM
Brinkley Ruth Williams (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/15/2021
3:07 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2021
4:29 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2021
4:28 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2021
6:41 PM
Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2021
6:40 PM
Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2021
6:39 PM
Rosenberg Noah L. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2021
6:38 PM
ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2021
6:35 PM
REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2021
6:34 PM
Clague Laura (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
3:44 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2021
8:30 PM
COUGHLIN TIMOTHY (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2021
8:26 PM
Bruhn Suzanne Louise (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2021
8:25 PM
Baynes Roy D. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2021
8:22 PM
LYONS GARY A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2021
8:21 PM
ASELAGE STEVE (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2021
8:19 PM
Meckler Jeffrey A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2021
8:17 PM
Orwin John A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2021
8:13 PM
Poole Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2021
8:11 PM
Squarer Ron (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
3:45 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2021
3:11 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2021
3:40 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form DEF 14A
04/06/2021
4:23 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form PRE 14A
03/01/2021
3:47 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/18/2021
5:26 PM
ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
1:40 PM
Consonance Capital Management LP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
02/12/2021
3:46 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2021
3:43 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 424B5
02/12/2021
2:48 PM
JANUS HENDERSON GROUP PLC (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G
02/12/2021
7:41 AM
MACQUARIE GROUP LTD (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G
02/11/2021
3:31 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
02/10/2021
4:29 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2021
3:40 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 424B5
02/09/2021
3:32 PM
Rosenberg Noah L. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
3:29 PM
Clague Laura (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
3:28 PM
Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
3:49 PM
Rosenberg Noah L. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
3:49 PM
ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
3:48 PM
Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
3:47 PM
REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
3:46 PM
Clague Laura (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2021
3:46 PM
Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
8:33 PM
Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
8:33 PM
Rosenberg Noah L. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
8:32 PM
ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
8:31 PM
REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
8:30 PM
Clague Laura (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
8:29 PM
Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
8:31 PM
Rosenberg Noah L. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
8:23 PM
ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
8:21 PM
REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
8:20 PM
Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
8:19 PM
Clague Laura (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
8:18 PM
ASELAGE STEVE (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
7:17 AM
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
01/28/2021
7:00 PM
Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4/A
01/25/2021
7:58 PM
ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
7:57 PM
Rosenberg Noah L. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
7:56 PM
REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
7:55 PM
Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
7:55 PM
Clague Laura (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
7:54 PM
Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
6:00 AM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2021
5:30 PM
REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
5:29 PM
Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
3:05 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G
12/16/2020
7:55 PM
ASELAGE STEVE (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2020
6:00 PM
ASELAGE STEVE (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2020
6:00 PM
Clague Laura (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
4:18 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2020
4:16 PM
Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K/A
11/17/2020
8:00 PM
ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2020
8:00 PM
Clague Laura (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2020
8:00 PM
REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2020
8:26 PM
REED ELIZABETH E (Reporting)
Retrophin, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:TVTX) was last updated on 12/8/2022 by MarketBeat.com Staff